GNOM Global X Genomics & Biotechnology ETF

Seeks to track, before fees and expenses, the Solactive Genomics Index.The Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology. Companies are only eligible if they generate at least 50% of their revenues from Genomics related business operations and/or are classified as “Biotechnology” according to the FactSet Industries and Economic Sectors classification system. To be eligible, a company must have it's primary listing in a developed market. Additionally, ADRs of any company whose primary listing is in a country that is part of the emerging markets are eligible. The top 40 companies are included in the Index.

$16.07  +0.34 (2.16%)
As of 08/12/2022 11:02:37 EST     IEX book   CBOE book


ETF Information
Sponsor:     Global X Funds
Category1:  Global Equity
Category2:  Single industry
Category3:  Healthcare
Morningstar category:  
Leverage factor:  1.00
Inception date:  04/09/2019
Index tracking method: Passive replication
Current yield:  0.05%
Historical average yield:  0.06%
Market cap:  $259,532,000
Average volume:  138,663
Fees:     0.6800%

Index Information
Solactive Genomics Index
Index symbol:  SOLGNOM
Provider:   Solactive
Index weighting:   Market capitalization
Index inception date:  03/26/2019
Backtesting data exists:   No
Number of holdings:  40

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy